iPharmaCenter|Healthcare| Pharma| Pharmaceutical industry| News|Blogs

ipharmaservices

2 days ago

American Society of Hematology (ASH) Annual Meeting | News | Updates | 2024 | iPharmaCenter

Genentech's Fixed-Duration Therapy Columvi and Lunsumio Showed Promise in Lymphoma Patients New data presented at the American Society of...

ipharmaservices

6 days ago

HUTCHMED and Innovent Announce Conditional Approval of Fruquintinib and Sintilimab Combination for Advanced Endometrial Cancer in China | iPharmaCenter

HUTCHMED and Innovent Biologics have announced that the China National Medical Products Administration (NMPA) has conditionally approved...